Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
<p>Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. With its investment through the Life Sciences Scale-Up Fund, the Ontario government is supporting healthcare innovation and reinforcing its province's leadership...</p>
Read original article ↗
Related Articles
SU Group Narrows First-Half Operating Loss, Executes on Long-Term Strategy
Business Momentum Led by Public-Sector Awards Across Healthcare, Cultural and Border Infrastructure Product Partnerships
SEMIFIVE Signs $52M AI Chip Development Deal with US Company
SEOUL, South Korea, Sept. 29, 2026 — SEMIFIVE, a leading global provider of custom AI semiconductor (ASIC) solutions, an